This compound is a pharmaceutical intermediate featuring a pyrrolidine ring with an amino group and a fluorine atom in specific stereochemical configuration. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1009075-48-2
TERT-BUTYL (3S,4R)-4-AMINO-3-FLUOROPIPERIDINE-1-CARBOXYLATE
Pharmaceutical intermediate
2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride
pharmaceutical intermediate
(S)-2-((1R,3aR,4S,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
pharmaceutical intermediate
Levofloxacin Q-Acid
Ofloxacin impurity reference standard
N-Phenyl-3-(trifluoromethyl)aniline
pharmaceutical intermediate
Tert-butyl (3S,4R)-3-amino-4-fluoropyrrolidine-1-carboxylate
Pharmaceutical intermediate
(3R,4R)-1-Boc-3-amino-4-fluoropyrrolidine
Pharmaceutical intermediate for drug synthesis
Tert-butyl (3S,4S)-3-amino-4-fluoropyrrolidine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
tert-butyl (3R,4S)-3-amino-4-fluoropyrrolidine-1-carboxylate
DXQXHFOCKKIWJL-NKWVEPMBSA-N
CC(C)(C)OC(=O)N1C[C@H]([C@H](C1)F)N
—